Search

everythinglearnresearchcommunity

for

Search:↓

Women with chronic hair loss had lower levels of zinc, copper, and ferritin than healthy women.

Most men seeking hair transplants have Male Pattern Baldness, influenced by genetics, age, and testosterone, while women's hair loss can be affected by thyroid function, iron, testosterone, prolactin, ferritin levels, and certain conditions. Follicular Unit Extraction is a popular hair transplant technique.

Korean women with female pattern hair loss have higher levels of ferritin, testosterone, and vitamin D than average.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Low serum levels of zinc and selenium may increase the risk of alopecia areata.

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

Iron profile tests are recommended for women with hair loss, as haemoglobin levels alone are not reliable.

H. pylori infection may be linked to the hair shedding condition Telogen Effluvium.

Stress, hypothyroidism, drug intake, and anemia are important factors in women's diffuse hair loss.

Dr. Shyam B Verma encourages more scientific research on hair disorders and criticizes the unscientific hair care market in India.

The guidelines suggest using various treatments, including antidepressants and steroids, for alopecia areata and discuss the condition's genetic and immune aspects.

Green tea compound EGCG could potentially treat colorectal cancer by removing iron and causing stress in cancer cells leading to their death.

Adults with Beta Thalassemia Major are more likely to have skin, hair, and nail disorders.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Patterned hair loss in women is linked to hormonal imbalances and biochemical changes, and should be evaluated for underlying health issues.

The document provided instructions for completing a CME exam on diagnosing and managing hair loss.

Genetics, low estrogen, and low iron levels contribute to female hair loss, with specific scalp signs indicating severity.

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

Finasteride caused blisters on hands and feet.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

A 4-year-old girl was diagnosed with erythrokeratodermia variabilis after other treatments failed.

A nutrition program improved a young woman's concussion symptoms.

A patient with lupus experienced a condition where their immune cells became overactive.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Treat hair loss in postmenopausal women with diet, avoiding certain drugs, and using medications like minoxidil or finasteride.

Taking finasteride daily can effectively and safely increase hair density and thickness for women with hair loss.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.